Madrigal Pharmaceuticals (NASDAQ:MDGL) granted equity inducement awards on July 1, 2026 to seven new non-executive employees under its 2025 Inducement Plan, approved by the independent Compensation Committee. Awards total 604 stock options and 2,952 time-based RSUs at a $514.39 exercise price, with multi-year vesting tied to continued employment.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – MDGL
+3.00%
2 alerts
+3.00%Session close to close
$12.18BMarket Cap
0.3xRel. Volume
In the Jul 7 session, MDGL gained 3.00%, reflecting a moderate positive market reaction.
Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
The company’s latest inducement awards, totaling 604 options and 2,952 RSUs at a $514.39 exercise pr...
Analysis
The company’s latest inducement awards, totaling 604 options and 2,952 RSUs at a $514.39 exercise price, continue a pattern of routine hiring-related grants. With elevated short interest and recent insider net selling, investors may watch how recurring equity awards intersect with overall supply-demand dynamics.
Key Figures
Stock options granted:604 optionsRSUs granted:2,952 restricted stock unitsOption exercise price:$514.39 per share+5 more
8 metrics
Stock options granted604 optionsAggregate inducement awards to seven new non-executive employees on Jul 1, 2026
RSUs granted2,952 restricted stock unitsAggregate time-based RSUs to seven new non-executive employees
Option exercise price$514.39 per shareEquals closing price of common stock on Jul 1, 2026 grant date
New employees7 employeesRecipients of inducement equity awards under 2025 Inducement Plan
Initial vesting tranche25% of option sharesVests on first anniversary of grant date, subject to continued employment
Subsequent vesting rate6.25% per quarterOption shares vest each quarterly anniversary after first year
RSU vesting schedule4 equal installmentsOn each of first through fourth anniversaries of grant date
Grant dateJuly 1, 2026Date equity inducement awards were granted
Inducement RSUs granted to 15 new non-executive employees under 2025 plan.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent administrative and inducement-award headlines have generally produced modest, mixed share-price reactions, with a larger move only around a conference participation update.
"approved by Madrigal’s independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
equity inducement awardsfinancial
"granted equity awards on July 1, 2026 to seven new non-executive employees as equity inducement awards"
Equity inducement awards are special stock-based rewards given to new employees to encourage them to join a company or stay long-term. They are like signing bonuses paid with company shares instead of cash, helping motivate employees to contribute to the company's success.
restricted stock unitsfinancial
"in the aggregate 2,952 time-based restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise pricefinancial
"Options have an exercise price of $514.39 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
inducement planfinancial
"as equity inducement awards under the terms of Madrigal’s 2025 Inducement Plan"
An inducement plan is a program a company creates to encourage employees or new hires to stay or join by offering special benefits or rewards. It’s like a company giving extra bonuses or perks to persuade someone to choose their job over others, helping the company attract and keep talented workers.
CONSHOHOCKEN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on July 1, 2026 to seven new non-executive employees as equity inducement awards under the terms of Madrigal’s 2025 Inducement Plan. The equity awards were approved by Madrigal’s independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4).
The equity awards were granted as an inducement material to employees’ acceptance of employment with the company. The new employees received, in the aggregate, options to purchase 604 shares of Madrigal’s common stock, and in the aggregate 2,952 time-based restricted stock units.Options have an exercise price of $514.39 per share, which is equal to the closing price of the company’s common stock on the grant date.Options vest as follows: (i) 25% of the option shares will vest on the first anniversary of the grant date and (ii) 6.25% of the option shares will vest on each quarterly anniversary following the first anniversary of the grant date.All restricted stock units granted vest in four equal installments on each of the first through fourth anniversaries of the grant date. The vesting of all awards described above shall be subject to each such employee’s continued employment as of the applicable vesting date.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra was the first medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com.
Investor Contact Tina Ventura, IR@madrigalpharma.com
Media Contact Christopher Frates, media@madrigalpharma.com
FAQ
What inducement equity awards did Madrigal (NASDAQ:MDGL) grant on July 1, 2026?
Madrigal granted stock options and restricted stock units to seven new non-executive employees. According to Madrigal, awards cover 604 options and 2,952 time-based RSUs as inducement grants under the 2025 Inducement Plan, tied to employees’ acceptance of employment with the company.
What is the exercise price of the new Madrigal (MDGL) stock options granted in July 2026?
The new Madrigal stock options have an exercise price of $514.39 per share. According to Madrigal, this matches the closing price of its common stock on the July 1, 2026 grant date, aligning option value with the company’s market price at issuance.
How do Madrigal (MDGL) July 2026 inducement stock options vest for new employees?
Madrigal’s inducement options vest over several years based on continued employment. According to Madrigal, 25% of option shares vest on the first anniversary, then 6.25% vest on each quarterly anniversary thereafter, encouraging long-term retention of the seven new non-executive employees.
What is the vesting schedule for Madrigal (MDGL) restricted stock units granted in July 2026?
The time-based RSUs vest in four equal annual installments. According to Madrigal, all 2,952 restricted stock units vest on each of the first through fourth anniversaries of the July 1, 2026 grant date, subject to each employee’s continued employment at each vesting date.
Under which plan were Madrigal (MDGL) July 2026 inducement awards granted and why?
The equity awards were granted under Madrigal’s 2025 Inducement Plan. According to Madrigal, they were approved by the independent Compensation Committee as inducement grants material to the employees’ acceptance of employment, in line with Nasdaq Listing Rule 5635(c)(4) requirements.
How many employees received Madrigal (MDGL) inducement equity awards on July 1, 2026?
Seven new non-executive employees received the July 1, 2026 equity awards. According to Madrigal, these individuals were granted, in the aggregate, options to purchase 604 shares and 2,952 time-based RSUs, structured as inducement awards connected to their hiring by the company.
